logo

Novabay Pharmaceuticals Inc (NBY) Stock: A Year of Highs and Lows in the Market

ELVT Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Novabay Pharmaceuticals Inc’s current trading price is -93.22% away from its 52-week high, while its distance from the 52-week low is 7.52%. The stock’s price range for this period has been between $0.12 and $1.95 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 10.67 million for the day, a number notably higher than the average daily volume of 3.08 million over the last three months.

Novabay Pharmaceuticals Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $1.95 on 04/21/23, while the lowest price for the same period was registered at $0.12 on 02/07/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Novabay Pharmaceuticals Inc (NBY) has experienced a quarterly decline of -51.41% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 0.86M and boasts a workforce of 33 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2282, with a change in price of -0.2380. Similarly, Novabay Pharmaceuticals Inc recorded 2,018,939 in trading volume during the last 100 days, posting a change of -64.31%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NBY stands at 0.43. Similarly, the long-term debt-to-equity ratio is also 0.18.

NBY Stock Stochastic Average

Novabay Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 7.86%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 10.14%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 13.01% and 15.49%, respectively.

NBY Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -35.17% this year. Over the last six months, there has been a stronger performance of -73.57%. The price of NBY leaped by -3.54% during the last 30 days period. For the last 5-days stocks have slided -7.00%.

Most Popular